Correction to “Gout Remission With Pegloticase‐Induced Intensive Urate‐Lowering Therapy: A Post Hoc Clinical Trial Analysis”

Documenti analoghi

• Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open‐Label Trial
  di: Orrin M. Troum, et al.
  Pubblicazione: (2025)
• Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate‐Lowering Therapy: A Phase 2, Randomized, Open‐Label, Multicenter, Active‐Controlled Trial
  di: Yiyun Yu, et al.
  Pubblicazione: (2025)
• Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study
  di: Toni J. F. Michael, et al.
  Pubblicazione: (2024)
• The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms
  di: Daniel H. Solomon, et al.
  Pubblicazione: (2025)
• Predicting Flare in Patients With Rheumatoid Arthritis in Biologic Induced Remission, on Tapering, and on Stable Therapy
  di: Hanna Gul, et al.
  Pubblicazione: (2024)